SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012382
Filing Date
2018-05-09
Accepted
2018-05-09 16:03:21
Documents
58
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ctmx-10q_20180331.htm 10-Q 1720445
2 EX-31.1 ctmx-ex311_9.htm EX-31.1 19574
3 EX-31.2 ctmx-ex312_7.htm EX-31.2 19583
4 EX-32.1 ctmx-ex321_6.htm EX-32.1 10157
5 EX-32.2 ctmx-ex322_10.htm EX-32.2 10520
  Complete submission text file 0001564590-18-012382.txt   6044057

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctmx-20180331.xml EX-101.INS 1217341
7 XBRL TAXONOMY EXTENSION SCHEMA ctmx-20180331.xsd EX-101.SCH 52802
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctmx-20180331_cal.xml EX-101.CAL 38104
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctmx-20180331_def.xml EX-101.DEF 210928
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctmx-20180331_lab.xml EX-101.LAB 313291
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctmx-20180331_pre.xml EX-101.PRE 298975
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37587 | Film No.: 18818215
SIC: 2834 Pharmaceutical Preparations